FT

Sanofi/GSK vaccine rollout delayed by poor results for elderly

Companies plan further studies with a different formulation

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button